Blog
Where our team of editors discuss what they think about the current NGP US Issues.
Editor NGP Europe
Latest News
Roche suspends drug development
Swiss-based pharmaceutical giant Roche have confirmed that, along with their partner Biogen Idec,...
read moreComments
EU research sequences human gut microbe genome
A new study by EU-funded researchers sheds new light on the influence that microbes in our guts...
read moreComments
AstraZeneca reveals cutback details
This week has seen AstraZeneca make good on previously-announced plans to cuts as many as 8000...
read moreComments
Homeopathy: hard to swallow?
MPs have argued that spending money on homeopathy is a waste of NHS money and that the money...
read moreComments
Experts advise WHO, 'pandemic yet to peak'
The director-general of the World Health Organisation has today said that it is too early to...
read moreComments
Merck post earnings, shares fall
Despite posting a decent set of figures for the fourth quarter of 2009 this morning, Merck KGaA...
read moreComments
Weekend round-up
Debates over data reliability, US regulatory concerns for GSK's asthma drug Advair and news of a...
read moreComments
Sanofi-aventis research deal
Leading drug maker sanofi-aventis have reportedly joined forces with France's National Alliance...
read moreComments
Sanofi to go after diabetes market
Sanofi-aventis, France's largest pharmaceutical company, is reportedly on track to secure the top...
read moreComments
Sanofi-aventis income jump
Reports are surfacing that suggest French pharmaceutical giant sanofi-aventis has seen an income...
read moreComments
NGP Europe Summit: Drug Discovery
1st - 3rd September 2010
The Next Generation Drug Discovery Summit Europe is designed to bridge the growing technological gap between drug discovery and drug development.
Source: www.ngpharma.eu.com© 2010 GDS Publishing Ltd. All rights reserved.